An episode of acute hepatitis in a patient with hemophilia during immunoadsorption therapy initially was misinterpreted as a reactivated hepatitis C virus (HCV) infection, but ultimately was shown to be an exogenous reinfection during cohort treatment with another HCV-positive patient. This incident illustrates that policies for the prevention of nosocomial transmission of blood-borne pathogens, especially in cohort treatment units, may need to be reassessed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1086/502063 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!